Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 3, 2013, Pages 535-540

  Krull, Kevin R ^a   Hockenberry, Marilyn J ^b   Miketova, Petra ^c   Carey, Marissa ^d   Moore, Ida M ^e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Cayman Pharma   (Czech Republic)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cerebral spinal fluid; Childhood leukemia; Neurocognitive; Phospholipids

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; METHOTREXATE; PHOSPHOLIPID; SPHINGOMYELIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRAIN LEVEL; CANCER CHEMOTHERAPY; CEREBROSPINAL FLUID LEVEL; CHILD; CHILDHOOD CANCER; COGNITION; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; WORKING MEMORY;

ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHOTREXATE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SPHINGOMYELINS; TIME FACTORS;

EID: 84873396317     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.717080     Document Type: Article

References (39)

1. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000: 15: 603-630.
2. Krull KR, Okcu MF, Potter B, et al. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol 2008;26: 4138-4143.
3. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;51: 99-104.
4. Kadan-Lottick NS, Brouwers P, Breiger D, et al. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2009;27: 5986-5992.
5. Armstrong FD, Mulhern R. Acute lymphoblastic leukemia and brain tumors. In: Brown RT, editor. Cognitive aspects of chronic illness in children. New York: Guilford Press: 1999. pp. 47-77.
6. Anderson V, Godber T, Smibert E, et al. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors. Pediatr Rehabil 1997: 1: 63-76.
7. Moore BD 3rd. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005;30: 51-63.
8. Hockenberry M, Krull K, Moore K, et al. Longitudinal evaluation of f ne motor skills in children with leukemia. J Pediatr Hematol Oncol 2007;29: 535-539.
9. Carey ME, Hockenberry MJ, Moore IM, et al. Briefreport: Effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 2007: 32: 189-193.
10. Reddick WE, Glass JO, Helton KJ, et al. Prevalence ofileukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 2005;26: 1263-1269.
11. Hertzberg H, Huk WJ, Ueberall MA, et al. CNSlateEffects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL-an evaluation of the interferences between morphology and neuropsychological performance. The German Late Efects Working Group. Med Pediatr Oncol 1997;28: 387-400.
12. Reddick WE, Shan ZY, Glass JO, et al. Smaller white-matter volumes are associated with larger def cits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006;106: 941-949.
13. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993;292: 617-629.
14. Fonteh AN, Harrington RJ, Huhmer AF, et al. Identification of disease markers in human cerebrospinal f uid using lipidomic and proteomic methods. Dis Markers 2006;22: 39-64.
15. Mielke MM, Bandaru VV, McArthur JC, et al. Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodef ciency virus. JNeurovirol 2010;16: 445-456.
16. Sacktor N, Haughey N, Cutler R, et al. Novel markers ofoxidative stress in actively progressive HIV dementia. J Neuroimmunol 2004: 157: 176-184.
17. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000: 30: 92-104.
18. Sheikh AM, Nagai A, Ryu JK, et al. Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia 2009: 57: 898-907.
19. Makinodan M, Tatsumi K, Okuda H, et al. Lysophosphatidylcholine induces delayed myelination in the juvenile ventral hippocampus and behavioral alterations in adulthood. Neurochem Int 2008;53: 374-381.
20. Mulder C, Wahlund LO, Teerlink T, et al. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fuidinAlzheimer's disease. JNeural Transm 2003;110: 949-955.
21. Borowitz MJ, Devidas M, Hunger SP, et al. Clinical signif cance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008: 111: 5477-5485.
22. Chauvenet AR, Martin PL, Devidas M, et al. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood 2007;110: 1105-1111.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226: 497-509.
24. Miketova P, Moore IM, Pasvogel A, et al. Determination of phospholipids as biomarkers of brain tissue damage in acute lymphoblastic leukemia patients. Scientific Papers of the University of Pardubice, Series A. Faculty of Chemical Technology 2003;8: 73-91.
25. Wechsler D. Wechsler Preschool and Primary Scales of Intelligence- Revised. New York: Harcourt, Brace, Jovanovich, Inc.: 1989.
26. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporatio n: 1999.
27. Wechsler D. Wechsler Intelligence Scale for Children-third edition. San Antonio, TX: Psychological Corporation: 1991.
28. Tifn J. Purdue Pegboard: examiner's manual. Chicago: Science Research Associates: 1968.
29. Torndike RL, Hagen EP, Sattler JM. Stanford-Binet Intelligence Scale: fourth edition. Chicago, IL: Riverside Publishing Company: 1986.
30. Beery KE. The Beery-Buktenica Developmental Test of Visual-Motor Integration: administration, scoring, and teaching manual. Parsippany, NJ: Modern Curriculum Press: 1997.
31. Woodcock RW, McGrew KS, Mather N. Woodcock-Johnson III: tests ofachievement. Itasca, IL: Riverside: 2001.
32. Bartzokis G, Lu PH, Tingus K, et al. Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging 2010: 31: 1554-1562.
33. Robinson KE, Livesay KL, Campbell LK, et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer 2010: 54: 585-590.
34. Tigyi G, Hong L, Yakubu M, et al. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. The American journal of physiology 1995;268: H2048-2055.
35. Kabarowski JH, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol 2002;64: 161-167.
36. Yan JJ, Jung JS, Lee JE, et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 2004;10: 161-167.
37. Ulloa L, Brunner M, Ramos L, et al. Scientific and clinical challenges in sepsis. Curr Pharm Des 2009;15: 1918-1935.
38. Blondeau N, Lauritzen I, Widmann C, et al. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002;22: 821-834.
39. Moore IM, Hockenberry MJ, Anhalt C, et al. Mathematics intervention for prevention of neurocognitive def cits in childhood leukemia. Pediatr Blood Cancer 2012;59: 278-284.